Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells

被引:38
作者
Vuylsteke, RJCLM
van Leeuwen, PAM
Meijer, S
Wijnands, PGJTB
Muller, MGS
Busch, DH
Scheper, RJ
de Gruijl, TD
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Surg Oncol, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, NL-1007 MB Amsterdam, Netherlands
[4] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany
关键词
D O I
10.1016/S0002-9440(10)64152-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immune responses against tumor antigens will initially occur in the first tumor-draining lymph node, the sentinel node (SN). Because of extensive diagnostic procedures, obtaining a piece of SN to isolate viable immune cells for functional analyses is often impossible. For this reason an alternative method to obtain viable cells from a lymph node (LN) was investigated, ie, scraping LNs with a surgical blade, and compared with dissociation of total LNs. Tumor-draining lymph nodes were retrieved from five oncological patients. The collected dendritic cells and T cells were phenotypically and functionally characterized by flow cytometry and antigen-specific interferon (IFN)-gamma release in an ELISPOT assay. Results were compared between the two isolation methods. Viabilities and phenotypic characteristics of the collected cells were entirely comparable for both methods. T-cell functionality was also comparable between both methods, with equal T-cell expansion factors and similar frequencies of cytotoxic T cells specifically recognizing the M1 matrix protein of Influenza haemophilus or the tumor antigen Her-2/neu. In conclusion, scraping LNs to obtain cells for analysis of immune functions in LNs is feasible and presents a good alternative to dissociation of LNs. Scraping may even be applied to small LNs that a pathologist will submit entirely for histological examination and may thus prove useful in the monitoring of immune responses in SNs.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 35 条
[1]   Tumor-specific granulocyte macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells [J].
Aruga, A ;
Shu, SY ;
Chang, AE .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (05) :317-324
[2]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients [J].
Benz, C ;
Utermöhlen, O ;
Wulf, A ;
Villmow, B ;
Dries, V ;
Goeser, T ;
Koszinowski, U ;
Busch, DH .
GASTROENTEROLOGY, 2002, 122 (05) :1201-1215
[5]   Comparison of aspiration, touch and scrape preparations simultaneously obtained from surgically excised specimens -: Effect of different methods of smear preparation on interpretive cytologic features [J].
Blumenfeld, W ;
Hashmi, N ;
Sagerman, P .
ACTA CYTOLOGICA, 1998, 42 (06) :1414-1418
[6]   Coordinate regulation of complex T cell populations responding to bacterial infection [J].
Busch, DH ;
Pilip, IM ;
Vijh, S ;
Pamer, EG .
IMMUNITY, 1998, 8 (03) :353-362
[7]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[8]   Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2 [J].
Chang, AE ;
Aruga, A ;
Cameron, MJ ;
Sondak, VK ;
Normolle, DP ;
Fox, BA ;
Shu, SY .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :796-807
[9]   Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: Implications for tumor biology and treatment [J].
Cochran, AJ ;
Morton, DL ;
Stern, S ;
Lana, AMA ;
Essner, R ;
Wen, DR .
MODERN PATHOLOGY, 2001, 14 (06) :604-608
[10]  
COCHRAN AJ, 1987, J NATL CANCER I, V78, P399